Literature DB >> 1059474

Chronic myelomonocytic leukaemia.

C G Geary, D Catovsky, E Wiltshaw, G R Milner, M C Scholes, S Van Noorden, L D Wadsworth, S Muldal, J E MacIver, D A Galton.   

Abstract

The natural history and haematological features of 18 patients with a chronic form of myelomonocytic leukaemia are described. The majority were elderly and, in this series, females predominated. Haematological prodomata, such as unexplained monocytosis, leucopenia, or thrombocytopenia were common, and the clinical onset was insidious. Splenomegaly was variable but tended to increase as the disease progressed. Anaemia was usually less than in the acute disease, unless compounded by iron deficiency. The blood film typically showed a mixed monocytosis and granulocytosis, cells in both lines showing abnormalities. 'Paramyeloid' cells, appearing in Romanowsky stained films intermediate between myelocytes and monocytes, were characteristic, although cytochemical and electron microscopical analysis suggests that these cells may be allotted to one or other cell line. The marrow aspirate was characteristically hypercellular, showed granulocytic hyperplasia, and, in contrast to the well-differentiated blood picture, the proportion of poorly differentiated cells, including blasts, was high. Serum lysozyme levels were usually raised. Five of the 18 cases survived more than 5 years, while 10 lived 2 years or longer. The morphological and clinical features form part of a spectrum including acute myelomonocytic leukaemia, into which several of the patients transformed. Recognition of the syndrome is important because the patients are probably best managed without intensive chemotherapy.

Entities:  

Mesh:

Year:  1975        PMID: 1059474     DOI: 10.1111/j.1365-2141.1975.tb00544.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  14 in total

1.  Proceedings: Chronic myelomonocytic leukaemia.

Authors:  C G Geary
Journal:  J Clin Pathol       Date:  1976-01       Impact factor: 3.411

2.  Portal hypertension and ascites in systemic mastocytosis.

Authors:  M N Narayanan; J A Liu Yin; S Azzawi; T W Warnes; W P Turck
Journal:  Postgrad Med J       Date:  1989-06       Impact factor: 2.401

Review 3.  Translational hematology.

Authors:  Klaus Geissler
Journal:  Wien Med Wochenschr       Date:  2014-09-10

4.  Treatment of chronic myelomonocytic leukemia. Vincristine and prednisone therapy during symptomatic phase or after transformation to acute leukemia.

Authors:  R Taetle; R Haerr
Journal:  West J Med       Date:  1985-10

5.  Chronic myelomonocytic leukemia: light and electron microscopy of the bone marrow.

Authors:  J Thiele; K F Vykoupil; A Georgii
Journal:  Blut       Date:  1979-09

Review 6.  Chronic myelomonocytic leukemia: Forefront of the field in 2015.

Authors:  Christopher B Benton; Aziz Nazha; Naveen Pemmaraju; Guillermo Garcia-Manero
Journal:  Crit Rev Oncol Hematol       Date:  2015-03-14       Impact factor: 6.312

7.  Intracellular lysozyme and lactoferrin in myeloproliferative disorders.

Authors:  D Y Mason
Journal:  J Clin Pathol       Date:  1977-06       Impact factor: 3.411

Review 8.  Myelodysplastic syndromes: their history, evolution and relation to acute myeloid leukaemia.

Authors:  D M Layton; G J Mufti
Journal:  Blut       Date:  1986-12

9.  Sucessful treatment of severe bone pain and acute arthritis in chronic myelomonocytic leukaemia by cytosine arabinoside.

Authors:  D Douer; A Weinberger; M Djaldetti; J Pinkhas
Journal:  Ann Rheum Dis       Date:  1977-04       Impact factor: 19.103

10.  [Myelomonocytic leukemia: clinical, cytological, and cytogenetic studies of acute, subacute, and chronic forms (author's transl)].

Authors:  S Mende; H H Fülle; A Knuth; I Weissenfels
Journal:  Blut       Date:  1977-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.